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Abstract 
BACKGROUND: Drug interaction is a term used to refer to unfavourable side effects caused by mixing or taking 
two or more drugs simultaneously. Although it is not possible to identify all drug interactions, awareness of 
therapeutic team of potential drug interactions, risk factors that enhance the possibility of these interactions and 
familiarity with mechanisms of drug interactions can help reduce real drug interactions.  
AIM: The present research seeks to study the frequency and intensity of possible interactions among various age 
groups and their correlation with doctor’s speciality, time of drug prescription, patient’s gender, etc. 
MATERIAL AND METHOD: This is observational, cross-sectional research conducted in spring and winter to 
study the prevalence of drug interactions among 6000 recipes belonging to 2 private and 2 public drug stores. The 
information associated with recipes was recorded, and drug interactions were studied based upon quick index of 
interactions using Up to Date software. Quick index of medical interactions is a response to data dealing with how 
drugs interact with one another. The risk factor is divided into groups A, B, C, D, and X according to this index 
with each one having its own definition. The data analysis was studied in terms of prevalence type of drug 
interactions and the possible correlation with other parameters. SPSS v.16 was used for statistical analysis.  
RESULTS: The average age of the patients was 42.07 ± 21.56 years. The frequency of male patients was 41.7%. 
An average number of 4.82 ± 1.91 drugs were prescribed for each patient and an average number of 1.95 ± 2.40 
drugs had interaction with one another with levels C, D, and X having the following drug interaction levels: 1.60 ± 
2.05, 0.275 ± 0.69, and 0.072 ± 0.31. No such interactions were observed in 31.1% (1846 cases) of recipes. The 
presence of drug interaction was statistically significant in terms of age, season, drug store and speciality of 
doctor (P-value < 0.05). The average number of interactions in the recipes issued by psychologists, cardiologists, 
rheumatologist, neurologists, and general practitioners was more, and this result was statistically significant (P-
value < 0.05).  
CONCLUSION: Considering the results achieved in this research, we may conclude that the drug interactions in 
recipes exhibit a noticeable frequency with the highest frequency observed in level C influenced by factors such 
as age, season, class of drugs, and expertise of the doctor. 
 
 
 
 
Introduction 
 
Drug interaction is a term used to refer to 
unwanted side effects caused by mixing or taking two 
or more drugs simultaneously. No such side effects 
are observed when the drugs are taken individually. 
Drug interaction may take place between various 
drugs, drugs prescribed by the doctor and those 
without a recipe, drugs and herbal medicines, 
supplementary drugs or vitamin supplements, drugs 
and some foods [1]. These interactions usually 
present themselves in a pharmacokinetic or 
pharmacodynamic fashion. In pharmacokinetic 
interactions, one drug may change metabolism, 
disposal or distribution of another medicine. In 
pharmacodynamic interventions, the exclusive 
function of drug changes as a result of other drugs’ 
influence [2]. Drug interactions are classified based 
upon the degree of importance, and this degree 
comprises intensity and evidence. The quick index of 
drug interactions is a response to data describing how 
drugs interact with one another. This index divides risk 
factor indexes to groups A, B, C, D, and X with each 
one having an exclusive definition. As we move from 
level A to level X, the urgency of response to drug 
interaction increases. Generally speaking, classes A 
and B are important only in scientific discussion, and 
no importance is attached to them in clinical 
discussions. However, the remaining three 
interactions always require clinical considerations [3].  
According to the report issued by American 
Association of Doctors, as many as 44 to 98 thousand 
deaths occur every year as a result of drug interaction 
with more than 7 thousand cases being the result of 
negative side effects of medicines. As many as 6.7% 
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of the patients in a hospital experience unfavourable 
drug side effects and this causes 0.34% of the death 
toll among them. In 2012, the death caused by the 
unfavourable side effects of interactions had the 4
th
 
place following cardiovascular diseases, diabetes, and 
AIDS in the U.S. [4]. The danger of occurrence and 
intensity of drug interventions are influenced by 
factors such as number of drugs taken, length of 
treatment, patient’s age, number of doctors 
prescribing the medicine and stage of disease [1], [4].  
Drug interaction is an important issue in drug 
safety, and it is a potential reason for the drug’s side 
effects among those patients hospitalised in the 
hospital. Their effect is well known as an important 
factor in drug therapy, and it may result in the total 
failure of the treatment process [5]. Drug interactions 
may potentially increase the death toll of patients as 
they cause unwanted side effects, reduce the 
effectiveness and increase the toxicity of medicine 
and impair patient’s cooperation with the treatment 
diet prescribed [6]. Drug interactions are estimated to 
be responsible for 20 to 30% of all unwanted medical 
reactions. These interactions require clinical action 
and consideration in 70% of the cases and may result 
in life-threatening incidents or death in 1 to 2% of the 
cases [7]. Although it is not possible to identify all drug 
interactions, awareness of therapeutic team of 
potential drug interactions, risk factors that enhance 
the possibility of these interactions and familiarity with 
mechanisms of drug interactions can help reduce real 
drug interactions [8].  
As there is no detailed and exact information 
concerning the prevalence of such interactions in Iran, 
and no research has been conducted on drug 
interactions in recipes of private and public drug 
stores in any Iranian cities, the present research 
seeks to study the frequency and intensity of possible 
interactions in various age groups, different classes of 
medicines and their correlation with doctor’s specialty, 
level of interactions and the correlation between the 
level of interactions with when the recipes were taken 
to these drug stores.  
 
 
Material and Methods 
 
This is observational, cross-sectional 
research conducted in spring and winter to study the 
prevalence of drug interactions in 2 private and 2 
public drug stores. According to calculations, as many 
as 3000 recipes were found for each season. Then, 
the information associated with these private and 
public drug stores including the name and number of 
drugs prescribed, doctor’s speciality, age and gender 
of patients, date of drug prescription and patient’s 
insurance coverage was recorded. Drug interaction 
was studied based on the quick index of interventions 
(Table 1) using Up to Date software. As levels A and 
B interventions are not clinically important; they are 
not reported here [9].  
Table 1: Different types of interventions and their classification 
Classification Interaction Definition 
A No 
intervention 
specified 
The data indicate no pharmacodynamic or pharmacokinetic 
interactions between factors 
B No action 
needed 
Data indicate drug interactions during simultaneous usage 
without any evidence indicating clinical concerns 
C Monitor 
Therapy 
Data indicate drug interactions with clinical symptoms. The 
good points of simultaneous use of these drugs are more 
than their harms. Appropriate monitoring is required for the 
potential negative effects. It is probably necessary to adjust 
the dose of one or both drugs during treatment. 
D Consider 
Therapy 
Modification 
The data show that drugs may have a clinical interaction 
with one another. It is necessary to exclusively examine 
each patient to see if the positive results outnumber the 
negative ones or not. It is also necessary to take the actions 
required to minimise the toxicity caused by simultaneous 
use. These actions may range from invasive monitoring, 
changing the empirical dose, and taking alternative 
measures 
X Preventing 
the 
interaction 
Data indicate interactions with clinical side effects. The 
dangers usually outweigh the benefits. The 
 
 
The data were analysed in terms of 
prevalence and type of medical interactions and 
possible correlation with other parameters. SPSS v.16 
was used for statistical analysis.  
 
 
Results 
 
The patients and recipes studied in this 
research numbered 6000 with 3000 recipes for winter 
and a similar number for the spring of 2015. The 
average age of the patients was 42.07 ± 21.56 years 
old. The frequency of male patients was 2500 (41.7%) 
people. To study drug interaction, only those recipes 
with at least two drugs were included. The average 
number of drugs in each recipe, the number of 
interacting medicines and the number of interacting 
medicines in terms of their interaction is presented in 
Table 2.  
Table 2: Frequency of variables 
Variable Average SD Minimum Maximum 
Number of drugs per recipe 4.820 1.91 2 16 
Number of interactions per recipe 1.95 2.40 0 21 
C interactions 1.60 2.05 0 20 
D interactions 0.275 0.69 0 13 
X interactions 0.072 0.31 0 5 
 
As many as 4 drug stores were selected as 
targets. As the approximate number of monthly 
recipes within that period was 8000 in Isar drug store 
and 6000 in three drug stores in Karaj, Sharyar, and 
Taleghan, a 30% share was defined for Isar drugstore 
(900 for each season) and the share of each of the 
three remaining drugstores was 23.3% (700 for each 
season). The frequency of insurance coverage was 
also studied in the recipes of patients. For this 
purpose, the insurances were divided into 4 
categories: Social Security, Medical Services, Armed 
Forces, and others. The frequencies of insurance 
among these patients were 76.8%, 15.5%, 6.9%, and 
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0.7% respectively. The expertise of those doctors 
prescribing the medicines was also studied (Figure 1). 
 
Figure 1: The frequency of doctors’ shares in the number of recipes 
 
The prevalence of drug interactions was 
studied based on different variables. The average 
number of interacting items with various levels of drug 
interactions was studied for each variable. The 
average number of interacting items in each 
interaction level is presented in Table 3. The result 
shows there is a significant relationship between all 
frequency of interaction and the average number of 
interacting items with various levels of interaction for 
each variable (p-value < 0.05), except the frequency 
of interaction between male and female and items C, 
X and total (p-value > 0.05). 
Table 3: The frequency of interaction and the average number 
of interacting items with various levels of interaction for each 
variable 
Variable Frequency of 
interaction (%) 
The average number of interacting items 
Total C D X 
gender Male 69.1 2.34 ± 
1.937 
2.00 ± 
1.596 
0.71 ± 
.0261 
0.32 ± 
0.079 
Female 68.9 2.44 ± 
1.948 
2.09 ± 
1.596 
0.68 ± 
0.284 
0.30 ± 
0.068 
P-value *0.865 **0.785 **0.387 **0.021 **0.097 
 
Age 
< 18 59.4 1.74 ± 
1.231 
1.61 ± 
1.125 
0.31 ± 
0.074 
0.17 ± 
0.029 
18-64 69.6 2.43 ± 
1.994 
2.05 ± 
1.607 
0.74 ± 
0.308 
0.32 ± 
0.079 
≥ 64 74.6 2.61 ± 
2.354 
2.31 ± 
1.962 
0.70 ± 
0.308 
0.34 ± 
0.083 
P-value ***0.000 ***0.000 ***0.000 ***0.000 ***0.000 
Season Winter 6.71 2.25 ± 
1.834 
1.95 ± 
1.517 
0.69 ± 
0.255 
0.27 ± 
0.060 
Spring 70.8 2.53 ± 
2.053 
2.14 ± 
1.675 
0.70 ± 
0.294 
0.34 ± 
0.084 
P-value *0.003 **0.001 **0.005 **0.003 **0.007 
 
Drug store 
Isar 70.1 2.32 ± 
1.891 
1.20 ± 
1.551 
0.69 ± 
0.278 
0.27 ± 
0.064 
Shahrya
r 
71.5 2.76 ± 
2.180 
2.30 ± 
1.801 
0.73 ± 
0.286 
0.39 ± 0.90 
Talegha
ni 
66.2 2.16 ± 
1.776 
1.90 ± 
1.447 
0.60 ± 
0.263 
0.26 ± 
0.063 
Karaj 67.7 2.31 ± 
1.941 
1.99 ± 
1.598 
0.75 ± 
0.270 
0.29 ± 
0.075 
P-value ***0.011 ****0.000 ****0.000 ****0.000 ****0.000 
Doctor General 76.5 2.46 ± 
2.235 
2.11 ± 
1.904 
0.76 ± 
0.255 
0.38 ± 
0.105 
Speciali
st 
64.4 2.34 ± 
1.768 
1.99 ± 
1.411 
0.71 ± 
0.304 
0.25 ± 
0.053 
P-value *0.000 **0.000 **0.000 **0.000 **0.000 
* Fisher’s Exact Test; ** Mann-Whitney U test; *** Pearson Chi-Square; **** Kruskal Wallis 
test. 
 
The prevalence of drug interactions was also 
studied based on the speciality of the doctor. 
According to the results, the prevalence of drug 
interactions among patients undergoing treatment 
under doctors with different specialities is significantly 
different (Table 4).  
Table 4: Prevalence of drug interactions in terms of the 
speciality of doctors 
 Drug interaction Total 
No Yes 
Number % Number % Number % 
General 530 23.5 1722 76.5 2252 100 
Cardiologist 98 22.9 330 77.1 428 100 
Neurologists 60 15.7 321 84.3 381 100 
Psychologists 32 9.4 307 90.6 339 100 
Pediatrician 183 55.5 147 44.5 330 100 
Gynecologist 241 59.5 164 40.5 405 100 
Urinary tract 71 43.6 92 56.4 163 100 
Infection 18 43.9 23 56.1 41 100 
Internist 183 35.3 335 64.7 518 100 
Glands 38 31.7 82 68.3 120 100 
Digestion 69 55.6 55 44.4 124 100 
Lungs 26 26.3 73 73.7 99 100 
Nephrology 31 27.0 84 73.0 115 100 
Emergency 
service 
30 35.3 55 64.7 85 100 
General 
surgery 
63 50.0 63 50.0 126 100 
Orthopedist 36 28.3 91 71.7 127 100 
Cancer 22 53.7 19 46.3 41 100 
Anesthesia 9 40.9 13 59.1 22 100 
Eye 31 63.3 18 36.7 49 100 
Ear, pharynx, 
nose 
54 53.5 47 46.5 101 100 
Radiology 1 50.0 1 50.0 2 100 
Skin 16 64.0 9 36.0 25 100 
Rheumatology 16 17.6 75 82.4 91 100 
Physical 
medicine 
5 31.3 4137 69.0 6000 100 
Total 1863 31.1 4137 69.0 6000 100 
 
 
The average number of interacting items in 
various levels of drug interventions was investigated 
about the type of doctors, including general 
practitioners and specialists, to determine the 
correlation between each class of interactions with 
doctor’s speciality.  
The average number of interacting items in 
each class of interaction can be observed in Figure 2. 
The difference across all variables was statistically 
significant (P-value = 0.000). 
 
Figure 2: The average number of interacting items in terms of the 
level of interaction in the recipe of each doctor 
 
The frequency of interaction was also 
calculated for various drug classes and reported in 
table 5. According to results, the drugs associated 
with the nervous system had a frequency of 38%.  
The drugs prescribed for the musculoskeletal 
system, alimentary tract and metabolism, and 
cardiovascular system had frequency levels of 19%, 
15% and 10%.  
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Table 5: Frequency of interaction in various classes of drugs 
Drug category Number of 
interactions 
Frequency 
(%) 
Nervous system 1574 38 
Musculoskeletal system 785 19 
Alimentary tract and metabolism 616 15 
Cardiovascular system 399 10 
Blood and blood-forming organs 228 6 
Antiinfectives for systemic use 150 4 
Systemic hormonal preparations, excl. Sex hormones and 
insulins 
140 3 
Respiratory system 108 3 
Genitourinary system and sex hormones 35 1 
Antiparasitic products, insecticides and repellents 25 0.608569 
Sensory organs 25 0.608569 
Antineoplastic and immunomodulating agents 18 0.438169 
Dermatologicals 5 0.121714 
 
 
 
Discussion 
 
Drug interaction is a general term used to talk 
about cases where the expected therapeutic effect of 
one medicine is modified by another. When two or 
more drugs are prescribed simultaneously, they may 
intervene with one another. As new drugs are 
introduced to the market every year, the importance of 
having medical information including awareness of 
contraindications, interventions and interactions of 
drugs with one another, the cautions and warnings 
associated with them, important side effects, etc. 
increases [3].  
According to the results of this research, an 
average number of 4.82 ± 1.91 items were prescribed 
for each patient of whom 1.95 ± 2.40 had drug 
interaction in each recipe with levels C, D, and X 
interactions having a share of 1.60 ± 2.05, 0.275 ± 
0.69, and 0.0 ± 072.31 respectively. No interactions 
were observed in 31.1% (1846 cases) of recipes. 
Crucial-Souza and Jaos Carlos Thomson 
(2006) conducted research and studied the frequency 
of drug interaction in an educational hospital in Brazil 
[10]. In this research, 300 recipes belonging to those 
patients hospitalised in the hospital were studied. This 
group utilised DrugReax system to analyse drug 
interaction. According to their results, drug 
interactions were observed in 49.7% of all recipes, 
while 3.4% of the recipes exhibited acute interactions. 
Compared to the results achieved in this research, the 
total frequency of interaction and acute interaction in 
the population studied in Iran was much less. 
According to their results, digoxin-hydrochlorothiazide 
interaction was the most common one. These two 
drugs played a minor role in the recipes studied in this 
research, and it might be due to the greater generality 
of the population studied in this research. The 
frequency of interaction and the average number of 
interacting items with various levels of interaction for 
the age variable shows there is a significant 
relationship between them. Also, according to the 
results of this research, the frequency of interaction 
among females older than 55 years suffering from 
cardiovascular diseases was significantly higher than 
other patients. In line with the results of the research 
conducted in Brazil, older age can influence drug 
interaction. 
Furthermore, gender has no significant 
influence on the occurrence of interactions except 
level D. As shown in Table 3; only level D has a 
significant difference in interaction. Although the 
frequency of intervention was so great among the 
recipes issued by cardiologists in our research, the 
greatest level of frequency was observed in the 
recipes issued by psychologists. This difference might 
be due to the large statistical population of our 
research.  
In 2003, Sabin S. Egger et al., [11] 
researched to study the frequency of drug interaction 
in the recipes of those patients who were being 
discharged from hospitals. As many as 500 patients 
were studied in this research and 60% of the recipes 
reported at least one drug interaction. According to 
this group, the level of frequency of low, average, and 
high interactions was 17.9%, 69.9%, and 12.2% 
respectively. This frequency is different from what we 
found in our research, and this difference can be 
attributed to the difference in the size of the 
population.  
Juan Merlo et al. (2001) published the results 
of the research they had conducted on all the recipes 
of January 1999 in Sweden [12]. As many as 962013 
recipes with at least 2 items fetched from the 
database of Swedish Health Organization were 
studied. Data were stratified by age and sex, and 
odds ratios were calculated using multilevel logistic 
regression. According to the results of their research, 
13.6% of all the recipes had at least one drug 
interaction. They claimed that factors such as older 
age and a higher number of drugs per recipe increase 
the possibility of a drug interaction. This fact is in line 
with the results of the current research. They also 
showed that level C drug interactions exhibited the 
greatest frequency in the Swedish population, and this 
result was also observed in the Iranian population, 
too. According to their research, level D drug 
interactions exhibited the second highest frequency in 
both the Iranian and Swedish population.  
Rachel P. Riechelmann et al., (2007) [13] 
studied drug interaction in the recipes of those 
patients who have cancer. They utilised Drug 
Interaction Facts software version 4.0 for their 
research. As many as 405 patients were studied in 
this research. Considering the items prescribed in 
each recipe, as many as 276 potential cases of drug 
intervention were predicted, but only 109 patients 
experienced such interactions. Nine of these 
interactions were acute, and 77% were mild. As it 
turned out in this research, the highest level of 
frequency was observed in drugs not associated with 
cancer such as warfarin, antihypertensive, 
corticosteroids and anticonvulsants. The authors 
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concluded that the prevalence of drug interaction in 
the population studied was influenced by the number 
of medical items in the recipe, the therapeutic method 
utilised and the tumour.  
In 2011, Fariba Ahmadizar et al., [14] studied 
the frequency of drug interactions in the recipes of 
general and specialised practitioners in Iranian 
population. As many as 28956638 recipes in 2007 
and 15510912 recipes in 2008 were collected from 
Iran Medical Sciences University and analysed using 
Pardazesh Nosakh, a prescription processing 
software program, provided by the National 
Committee of Rational Drug Use. This program was 
developed for the DOS operating system and Novell 
Network in 1998. Drug interactions were observed in 
the recipes issued by internists, cardiologists, 
neurologists, psychiatrists, neurosurgeons, general 
surgeons, infectious diseases specialists, urologists, 
dermatologists, ear, throat and nose specialists, 
optometrists, orthopedists, and paediatricians. 
According to the results, the highest degree of 
frequency was observed in the recipes issued by 
cardiologists, internists, urologists, and neurologists. 
Similar to the results achieved in our research, 
cardiologists and neurologists have the greatest share 
in drug interactions.  
In conclusion, considering the results 
achieved in this research, a noticeable frequency was 
found for drug interaction in recipes. The highest 
frequency of drug interaction was observed in level C 
interactions. On the other hand, it has been proved 
that factors such as age increase the possibility of 
interactions, and as people grow older, the number of 
interacting items and level of interaction goes up. As 
some diseases are dependent upon season, the time 
and season when the drug is prescribed can also 
increase the possibility of drug interactions. 
Furthermore, gender has no significant influence on 
the occurrence of interactions except level D. As 
shown; only level D has a significant difference in 
interaction. Type of drug store and patients’ insurance 
coverage were the other factors that had a noticeable 
influence on the occurrence of interactions. The 
frequency of these interactions in the class of the 
nervous system and the musculoskeletal system was 
so great. Doctor’s speciality also plays a major role in 
the occurrence of interactions with greater degrees of 
frequency observed in the recipes of general 
practitioners. As of specialists, the highest rate of 
interaction was observed in the items issued by 
psychiatrists.  
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